RO5429083
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RO5429083, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO5429083 Alone or in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia [Phase 1]